Mayo Clinic, an existing partner of the biomedical data platform developer, has contributed to its $60m series B round.
Month: January 2020
Soul Machines sources $40m
The avatar software provider has ramped up its series B round to $40m, adding Salesforce Ventures to a consortium that already included Daimler.
Deep Genomics dives for $40m
Bloomberg Beta-backed Deep Genomics will use the series B funding to advance drug candidates created through its artificial intelligence drug development model.
Tencent lends help as VIPKid spinoff raises $80m
VIPKid investor Tencent has participated in an $80m series A round for its livestreamed tutoring offshoot, Dami Wangxiao.
GNS Healthcare gees up series D to $28m
The medical data analytics platform has raised $5m from Merck Global Health Innovation Fund, adding to $23m raised last year.
Lightspeed POS processes Gastrofix purchase
Hospitality-focused payment services provider Gastrofix has agreed to a nine-figure acquisition that will enable Radeberger to exit.
TwinStrand completes $16m series A sequence
Existing investor Alexandria Venture Investments has helped genetic sequencing technology developer TwinStand increase its overall funding to $21.5m.
Quibi cribs another $400m
The bite-sized video streaming platform, which counts a host of corporates among its investors, has revealed $400m in funding along with its launch date.
ClassPass clinches $285m series E
The GV-backed fitness and wellness subscription service secured a unicorn valuation in a round that lifted its overall funding to $540m.
Tiger Global buys into Byju’s with $200m
The educational app developer, which counts Tencent, Naspers and BCC among its investors, raised the money at a valuation of about $8bn.
VectivBio selects Novo for $35m round
Novo took part in the first round for VectivBio, a short bowel syndrome treatment developer launched out of genetic disease drug developer Therachon.
Virtual Incision sews up $20m in funding
The colectomy-focused surgical device developer, which counts SinoPharm as an earlier investor, has secured series B-plus funding, in a round led by Bluestem Capital.
Galecto gallops to PharmAkea merger
Galecto, whose investors include Novo, Merck Group and Bristol-Myers Squibb, is merging with Celgene-backed PharmAkea, with the joint entity retaining the Galecto name and leadership team.
Roofstock locks up $50m series D
Citi Ventures joined Roofstock’s shareholders in a series D round that increased the property investment platform’s overall funding to $133m.